The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Videos  >  

Novel Agents for Neoadjuvant TNBC Treatment

Anees B. Chagpar, MD
Published Online:3:02 PM, Wed March 29, 2017

Anees B. Chagpar, MD, associate professor of Surgery (Oncology), director of The Breast Center at Smilow Cancer Hospital at Yale-New Haven, Yale Cancer Center, discusses novel agents for neoadjuvant triple-negative breast cancer (TNBC) treatment.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.